Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Total 13F shares
-
4,719,905
-
Share change
-
-196,053
-
Total reported value
-
$342,444,031
-
Price per share
-
$72.56
-
Number of holders
-
150
-
Value change
-
-$13,869,438
-
Number of buys
-
50
-
Number of sells
-
50
Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q3 2025
As of 30 Sep 2025,
ISHARES TR - U.S. PHARMA ETF (IHE) was held by
150 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,719,905 shares.
The largest 10 holders included
Fisher Asset Management, LLC, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, BANK OF AMERICA CORP /DE/, LPL Financial LLC, JPMORGAN CHASE & CO, ROYAL BANK OF CANADA, BNP PARIBAS FINANCIAL MARKETS, BROWN ADVISORY INC, and RAYMOND JAMES FINANCIAL INC.
This page lists
150
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.